Enzymatic synthesis of 2'-O-acyl prodrugs of 1-(β-D-arabinofuranosyl)-5(E)-(2-bromovinyl)uracil and of 2'-O-acyl-araU, -araC and -araA

Antiviral Chemistry and Chemotherapy

Volumn 9, Issue 1, 1998, Pages 25-31

  Manfredini, S ^a   Baraldi, P G ^a   Bazzanini, R ^a   Bortolotti, F ^a   Vertuani, S ^a   Ashida, N ^b   Machida, H ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b YAMASA CORPORATION   (Japan)

Author keywords

2' O acyl arabinofuranosyl nucleosides; Anti VZV activity; Pig liver esterase; Sorivudine

Indexed keywords

CYTARABINE DERIVATIVE; ESTERASE; NUCLEOSIDE DERIVATIVE; PRODRUG; SORIVUDINE; URACIL ARABINOSIDE; VIDARABINE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HYDROLYSIS; IN VITRO STUDY; LIVER; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS;

EID: 0031985766     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029800900103     Document Type: Article

References (21)

1. Alrabiah FA & Sacks SL (1996) New antiherpesvirus agents. Drugs 52:17-32.
2. Ayisi N, Wall R, Wanklin R, Machida H, De Clercq E & Sacks SL (1987) Comparative metabolism of E-5-(2-bromovinyl)-2′-deoxyuridine and 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells. Molecular Pharmacology 31:422-429.
3. Baker D, Haskell TH, Putt S & Sloan B (1979) Prodrugs of 9-(β-D-arabinofuranosyl)adenine. 2. Synthesis and evaluation of a number of 2′,3′- and 3′,5′-di-O-acyl derivatives. Journal of Medicinal Chemistry 22:273-279.
4. Baraldi P, Bazzanini R, Manfredini S, Simoni D & Robins M (1993) Facile access to 2′-O-acyl prodrugs of 1-(β-D-arabinofuranosyl)-5(E)-(2-bromovinyl)uracil (BVAraU) via regioselective esterase-catalyzed hydrolysis of 2′,3′,5′-triesters. Tetrahedron Letters 34:3177-3180.
5. Beranek J & Drasar P (1977) Analogs of nucleosides. XIII. Selective O-acylation. Preparation of 1-(2,3,5-tri-O-acetyl-β-D-arabino-pentofuranosyl)cytosine hydrochloride. Collection of Czechoslovak Chemical Communications 42:366-369.
6. Brown D, Todd A & Varadarajan S (1956) Nucleotides. Part XXXVII. The structure of uridilyc acids a and b, and a synthesis of spongouridine (3-β-D-arabynofuranosyl-uracil). Journal of the Chemical Society 2388-2393.
7. De Clercq E (1995) Trends in the developments of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses. Reviews in Medical Virology 5:149-164.
8. Haskell T (1977) Relation of structure and antiviral activity of 9-β-D-arabinouranosyladenine analogs. Annals of the New York Academy of Sciences 284:81-90.
9. Ishido Y, Sakairi N, Okazaki K & Nakazaki N (1980) Partial protection of carbohydrate derivatives. Part 4. Regioselective 2′-O-deacylation of fully acylated purine and pyrimidine ribonucleosides with hydroxylaminium acetate. Journal of the Chemical Society Perkin Transactions I 563-573.
10. Kano F, Ijichi K, Ashida N, Watanabe Y, Sakata S & Machida H (1994) 5′-O-Alkyl and acyl prodrugs of 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Antiviral Chemistry & Chemotherapy 5:74-82.
11. Kawaguchi T, Suzuki Y, Nambu N & Nagai T (1985) Specificity of esterases and structures of prodrug esters. III. Activity of rat tissue homogenates, rat plasma and porcine pig liver esterase for the hydrolysis of 3′,5′-bis-dicarboxylic acid hemiesters of 5-fluoro-2′-deoxyuridine. Chemical and Pharmaceutical Bulletin 33:2956-2961.
12. Machida H & Nishitani N (1990) Drug susceptibilities of isolates of varicella zoster virus in a clinical study of oral brovavir. Microbiology & Immunology 34:407-411.
13. Machida H, Nishitani M & Ashida N (1994) Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure. Microbiology & Immunology 38:109-115.
14. Machida H, Nishitani M, Watanabe Y, Yoshimura Y, Kano F & Sakata S (1995) Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues. Microbiology & Immunology 39:201-206.
15. Manfredini S, Simoni D, Ferroni R, Bazzanini R, Vertuani S, Hatse S, Baizarini J & De Clercq E (1997) Retinoic acid conjugates as potential antitumor agents. Synthesis and biological activity of conjugates with ara-A, ara-C, the 3(2H) furanone and aniline mustard moieties. Journal of Medicinal Chemistry 40: 3851-3857.
16. Philip G & Jones J (1992) Dilemma regarding an active site model for porcine pancreatic lipase. Tetrahedron Letters 112:1399-1402.
17. Robins MJ & Manfredini S (1990) Conversion of vinylsilanes to vinylhalides with xenon difluoride and metal halides. A versatile new route to 5-(2-halovinyl)pyrimidine nucleosides. Tetrahedron Letters 31:5633-5636.
18. Singh H, Cote G & Sikorski R (1993) Enzymatic regioselective deacylation of 2′,3′,5′-tri-O-acylribo-nucleosides: enzymatic synthesis of 2′,3′-di-O-acylribonucleosides. Tetrahedron Letters 34:5201-5204.
19. Uemura A, Nozaki K, Yamashita J & Yasumoto M (1989) Regioselective deprotection of 3′,5′-O-acylated pyrimidine nucleosides by lipase and esterase. Tetrahedron Letters 30:3819-3823.
20. Wong C & Whitesides G (editors) (1994) Use of hydrolytic enzymes. Enzymes in Synthetic Organic Chemistry, pp. 41-130. Oxford: Pergamon Press.
21. Zhang W & Robins M (1992) Removal of silyl protecting groups from hydroxyl functions with ammonium fluoride in methanol. Tetrahedron Letters 33:1177-1180.